Send password reminder...
Subscribe to New Research on ONO 1603
a prolyl endopeptidase inhibitor
Also Known As:
relevant articles (
Bio-Agent Context: Research Results
Heterocyclic Compounds: 60
1-Ring Heterocyclic Compounds
ONO 1603: 1
Alzheimer Disease (Alzheimer's Disease)
08/23/1996 - "
The common actions of ONO-1603 and THA suggest that these properties could be related to their putative antidementia activities and that this model system may be used to screen for drugs effective in the treatment for Alzheimer's disease.
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
We wish to acknowledge and thank the US National Library of Medicine and Medline staff for providing access to their data.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.